Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy

Osteoporosis-related fractures are a major public health problem and one in two women and one in four men are affected with osteoporosis-related fractures. Alendronate (Fosamax) is one of the first bisphosphonates used to treat osteoporosis effectively. Recently, however, there is a concern regardin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gudena, Ravindra, Werle, Jason, Johnston, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135260/
https://www.ncbi.nlm.nih.gov/pubmed/21776372
http://dx.doi.org/10.4061/2011/810697
_version_ 1782208079647997952
author Gudena, Ravindra
Werle, Jason
Johnston, Kelly
author_facet Gudena, Ravindra
Werle, Jason
Johnston, Kelly
author_sort Gudena, Ravindra
collection PubMed
description Osteoporosis-related fractures are a major public health problem and one in two women and one in four men are affected with osteoporosis-related fractures. Alendronate (Fosamax) is one of the first bisphosphonates used to treat osteoporosis effectively. Recently, however, there is a concern regarding long bone insufficiency fractures related to long-term alendronate therapy. We report a case of bilateral femoral insufficiency fractures likely related to long-term alendronate therapy, the classic symptoms, signs, and treatment of these fractures.
format Online
Article
Text
id pubmed-3135260
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-31352602011-07-20 Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy Gudena, Ravindra Werle, Jason Johnston, Kelly J Osteoporos Case Report Osteoporosis-related fractures are a major public health problem and one in two women and one in four men are affected with osteoporosis-related fractures. Alendronate (Fosamax) is one of the first bisphosphonates used to treat osteoporosis effectively. Recently, however, there is a concern regarding long bone insufficiency fractures related to long-term alendronate therapy. We report a case of bilateral femoral insufficiency fractures likely related to long-term alendronate therapy, the classic symptoms, signs, and treatment of these fractures. SAGE-Hindawi Access to Research 2011-05-05 /pmc/articles/PMC3135260/ /pubmed/21776372 http://dx.doi.org/10.4061/2011/810697 Text en Copyright © 2011 Ravindra Gudena et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gudena, Ravindra
Werle, Jason
Johnston, Kelly
Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
title Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
title_full Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
title_fullStr Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
title_full_unstemmed Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
title_short Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
title_sort bilateral femoral insufficiency fractures likely related to long-term alendronate therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135260/
https://www.ncbi.nlm.nih.gov/pubmed/21776372
http://dx.doi.org/10.4061/2011/810697
work_keys_str_mv AT gudenaravindra bilateralfemoralinsufficiencyfractureslikelyrelatedtolongtermalendronatetherapy
AT werlejason bilateralfemoralinsufficiencyfractureslikelyrelatedtolongtermalendronatetherapy
AT johnstonkelly bilateralfemoralinsufficiencyfractureslikelyrelatedtolongtermalendronatetherapy

Ejemplares similares